References
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.30207593
- Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-631812369
- Vaccarella S, Lortet-Tieulent J, Plummer M, et al. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer. 2013;49(15):3262–3273. doi:10.1016/j.ejca.2013.04.02423751569
- Small W, Bacon MA, Bajaj A, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–2412. doi:10.1002/cncr.3066728464289
- Crow JM. HPV: the global burden. Nature. 2012;488(7413):S2–S3. doi:10.1038/488S2a22932437
- Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881. e13. doi:10.1016/j.cell.2018.12.02130735636
- Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035–1045. doi:10.1080/15476286.2016.127152427982727
- Hsiao K-Y, Sun HS, Tsai S-J. Circular RNA–new member of noncoding RNA with novel functions. Exp Biol Med. 2017;242(11):1136–1141. doi:10.1177/1535370217708978
- Zhang Z, Xie Q, He D, et al. Circular RNA: new star, new hope in cancer. BMC Cancer. 2018;18(1):1–10. doi:10.1186/s12885-018-4689-729291726
- Xu Y, Yu J, Huang Z, et al. Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression. J Exp Clin Cancer Res. 2020;39(1):1–14. doi:10.1186/s13046-020-01556-431928527
- Zhu K-P, Zhang C-L, Ma X-L, et al. Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance. Mol Therapy. 2019;27(3):518–530. doi:10.1016/j.ymthe.2019.01.001
- Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674–686. doi:10.1001/jama.2018.1089730140884
- Vu M, Yu J, Awolude OA, et al. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–465. doi:10.1016/j.currproblcancer.2018.06.00330064936
- Kessler TA. Cervical Cancer: Prevention and Early Detection. In Seminars in Oncology Nursing. Elsevier; 2017.
- Chaichian S, Shafabakhsh R, Mirhashemi SM, et al. Circular RNAs: a novel biomarker for cervical cancer. J Cell Physiol. 2020;235(2):718–724. doi:10.1002/jcp.2900931240697
- Song T, Xu A, Zhang Z, et al. CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR‐8075. J Cell Physiol. 2019;234(8):14296–14305. doi:10.1002/jcp.2812830633364
- Zhang S, Chen Z, Sun J, et al. CircRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis. Cancer Cell Int. 2020;20(1):1–12. doi:10.1186/s12935-019-1086-531908598
- Ou R, Mo L, Tang H, et al. circRNA-AKT1 Sequesters miR-942-5p to Upregulate AKT1 and Promote Cervical Cancer Progression. Mol Therapy Nucleic Acids. 2020;20:308–322. doi:10.1016/j.omtn.2020.01.003
- Han M, Hu J, Lu P, et al. Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer. Cell Death Dis. 2020;11(1):1–15. doi:10.1038/s41419-020-2250-531911576
- Zhang F, Li K, Yao X, et al. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer. EBioMedicine. 2019;44:311–321. doi:10.1016/j.ebiom.2019.05.00331078520
- Yu C, Tian F, Liu J, et al. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR‐567/PTPRG regulatory pathway. Cell Prolif. 2019;52(3):e12610. doi:10.1111/cpr.1261031012177
- Liu D, Zhang C, Li X, et al. MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma. EXCLI j. 2018;17:102. doi:10.17179/excli2017-93229743851
- Sun Y, Gou D, Liu H, et al. The KRAB domain of zinc finger gene ZNF268: a potential transcriptional repressor. IUBMB Life. 2003;55(3):127–131. doi:10.1080/152165403100011020812822888
- Zhao Z, Wang D, Zhu C, et al. Aberrant alternative splicing of human zinc finger gene ZNF268 in human hematological malignancy. Oncol Rep. 2008;20(5):1243–1248.18949428
- Hu L, Wang W, Cai J, et al. Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cells. Oncol Lett. 2013;6(1):49–54. doi:10.3892/ol.2013.131823946776
- Wang D, Guo M-X, Hu H-M, et al. Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway. J Biol Chem. 2008;283(24):16299–16308. doi:10.1074/jbc.M70642620018375384
- Wang W, Guo M, Hu L, et al. The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-κB signaling. J Biol Chem. 2012;287(51):42856–42866. doi:10.1074/jbc.M112.39992323091055